Novartis
Price
Price
Historical dividends and forecast
Novartis has so far distributed $3.761 in 2024. The next dividend will be paid on 11.03.2025
CHART BY
Frequently asked questions
What is Novartis's market capitalization?
What is Novartis's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Novartis?
What are the analyst ratings and target price for Novartis's stock?
What is Novartis's revenue over the trailing twelve months?
What is the EBITDA for Novartis?
What is the free cash flow of Novartis?
What is the 5-year beta of Novartis's stock?
How many employees does Novartis have, and what sector and industry does it belong to?
What is the free float of Novartis's shares?
Financials
Market Cap
$224.86B5Y beta
0.93EPS (TTM)
$8.534Free Float
1.91BP/E ratio (TTM)
12.03Revenue (TTM)
$49.81BEBITDA (TTM)
$20.24BFree Cashflow (TTM)
$5.52BPricing
Analyst Ratings
The price target is $111.54 and the stock is covered by 26 analysts.
Buy
11
Hold
13
Sell
2
Information
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.
76,057
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker